Literature DB >> 6417259

Tolerance for self IG at the level of the Ly1+ T cell.

E K Bikoff.   

Abstract

Experiments presented in this report demonstrate that specificity of the Ly1+ T cell proliferative response to NP-modified Ig is controlled by Igh-C-linked genes. In addition, we describe the mechanism whereby Igh-C-encoded molecules influence Ly1+ T cell activity. We show that Igh-C-linked control of T cell responses to NP-modified Ig is a secondary consequence of naturally acquired tolerance for self Ig. Unresponsiveness to self Ig is not due to a defect expressed functionally at the level of the antigen-presenting cell, nor is it associated with active suppression. These results suggest that tolerance for self Ig at the level of the Ly1+ T cell is due to functional deletion of Ly1+ T cell clones specific for self Ig. The possibility is considered that regulatory effects mediated by passively administered antibodies may in part be due to induction of Ly1+ T cell tolerance for self Ig.

Mesh:

Substances:

Year:  1983        PMID: 6417259      PMCID: PMC2187155          DOI: 10.1084/jem.158.6.1868

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  51 in total

1.  Detection of anti-idiotype reactive cells in the response to phosphorylcholine.

Authors:  H Cosenza
Journal:  Eur J Immunol       Date:  1976-02       Impact factor: 5.532

2.  Induction of T and B cell immunity by anti-idiotypic antibody.

Authors:  K Eichmann; K Rajewsky
Journal:  Eur J Immunol       Date:  1975-10       Impact factor: 5.532

3.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

4.  Influence of Igh-C- and MHC-linked genes on the activity of immunoglobulin-recognizing T cells.

Authors:  E Bikoff; C A Bona
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

5.  Anti-idiotypic antibody in rat transplantation immunity. I. Production of anti-idiotypic antibody in animals repeatedly immunized with alloantigens.

Authors:  T J McKearn; F P Stuart; F W Fitch
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

6.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

7.  Specific suppression of the immune response by HGG tolerant spleen cells. I. Parameters affecting the level of suppression.

Authors:  M V Doyle; D E Parks; W O Weigle
Journal:  J Immunol       Date:  1976-06       Impact factor: 5.422

8.  Regulation of immune response by autogenous antibody against receptor.

Authors:  L Kluskens; H Köhler
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

9.  Studies of idiotypic antibodies. Production and characterization of autoantiidiotypic antisera.

Authors:  L S Rodkey
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

10.  T-cell regulation of antibody responses: demonstration of allotype-specific helper T cells and their specific removal by suppressor T cells.

Authors:  L A Herzenberg; K Okumura; H Cantor; V L Sato; F W Shen; E A Boyse; L A Herzenberg
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

View more
  3 in total

1.  Control of autoantibody affinity by selection against amino acid replacements in the complementarity-determining regions.

Authors:  M Børretzen; I Randen; E Zdárský; O Førre; J B Natvig; K M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

2.  New Relationships for Old Autoantibodies in Rheumatoid Arthritis.

Authors:  Miriam A Shelef
Journal:  Arthritis Rheumatol       Date:  2019-08-01       Impact factor: 15.483

3.  Activation and tolerance in CD4(+) T cells reactive to an immunoglobulin variable region.

Authors:  Christopher M Snyder; Katja Aviszus; Ryan A Heiser; Daniel R Tonkin; Amanda M Guth; Lawrence J Wysocki
Journal:  J Exp Med       Date:  2004-06-28       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.